vasodilators such as prostacyclin and endothelial-derived relaxing factor, or nitric oxide, has led to the popular theory Nitric oxide (NO) regulates blood flow in the human that the vascular manifestations of pre-eclampsia can be placenta. As increased resistance to blood flow is seen in ascribed to deficient production of these mediators. Indeed, the fetal-placental vasculature in pregnancies complicated inhibition of nitric oxide synthesis in pregnant rats results in by pre-eclampsia and/or intrauterine growth restriction a pre-eclampsia-like condition (Buhimschi et al., 1995) ; an (IUGR), we examined expression of endothelial nitric oxide effect that can be reversed by treatment with the vasodilator synthase (eNOS) in these placentas. Placental villous tissue calcitonin gene-related peptide (Yallampalli et al., 1996) . sections were obtained from normotensive control (n ⍧ 5),
Although a generalized reduction of prostacyclin synthesis is IUGR alone (n ⍧ 5) or pre-eclamptic (with or without well described in pre-eclampsia (Goodman et al., 1982) , the IUGR) (n ⍧ 9) patients, immunostained for eNOS and evidence for reduction in nitric oxide synthesis is less convinscored for localization, type (punctate or diffuse) and cing (Cameron et al., 1993; Seligman et al., 1994 ; Lyall intensity of eNOS staining in syncytiotrophoblast and et al., 1995) . placental vessels. The significance of differences was calcu-
The nitric oxide radical (NO) is generated from the metabollated using the Mann-Whitney U-test. No differences in ism of L-arginine by the enzyme nitric oxide synthase (NOS) intensity or type of immunostaining in syncytiotrophoblast (Moncada and Higgs, 1993) , of which there are three isoforms were seen. Placentas from patients with pre-eclampsia with (Lowenstein et al., 1994) . Nitric oxide acts via binding to or without IUGR had a significantly more basal distribution haem-containing proteins, thus altering their activity (Tsai, of eNOS in syncytiotrophoblast. eNOS immunostaining 1994). For example, NO from endothelial cells diffuses to was absent in terminal villous capillary and faint in stem underlying smooth muscle where it activates guanylate cyclase, villous vessel endothelium of normal placentas, but was increases cGMP formation and leads to vascular relaxation intense in the endothelium of both of these types of vessels (Waldman and Murad, 1988) . We have described the action in the IUGR and pre-eclampsia groups, with significantly of NO in the human fetal-placental vasculature (Myatt et al. , greater staining seen in stem vessels of patients with IUGR 1991 IUGR , 1992 and mapped the distribution of the endothelial or alone. This increased eNOS expression and hence increased type III NOS isoform (eNOS) in the vasculature and trophoblast NO production in the fetal-placental vasculature may be of the human placenta (Myatt et al., 1993) . an adaptive response to the increased resistance and poor Using Doppler flow velocity waveforms, it has been reported perfusion in these pathological pregnancies.
that resistance to blood flow increases in the fetal-placental Key words: endothelium/nitric oxide/placenta/pre-eclampsia/ vascular tree in pregnancies complicated by either pre-eclamptrophoblast sia and/or intrauterine growth restriction (IUGR) . This increase has been ascribed to altered vascular reactivity (perhaps dependent on NO synthesis and action) or Introduction to alterations in vascular architecture in the placental villous tree . We have previously described eNOS Pre-eclampsia is a leading cause of maternal and perinatal protein expression in the pre-eclamptic placenta using immunomorbidity and mortality (Roberts, 1994) . It is often associated histochemistry (Ghabour et al., 1995) . In contrast to normowith fetal growth restriction and affects up to 7% of pregnant tensive placentas, eNOS immunostaining was seen in small women. The aetiology of this disease remains poorly underterminal villous vessels with underlying smooth muscle in preeclamptic placentas. It is possible that this expression of eNOS may be secondary to vascular alterations that occur in pre-*Presented in part at the 42nd Annual Meeting of the Society for Gynecologic Investgation, Chicago, March 15-18, 1995. eclamptic placentas, but may impinge upon regulation of placental vascular reactivity by the underlying smooth muscle 
NO, were significantly higher at delivery in umbilical venous blood from both pre-eclamptic (Lyall et al., 1995) and IUGR Age (years) 32.6 Ϯ 4.2 31.0 Ϯ 4.2 26.1 Ϯ 6.7 (Lyall et al., 1996) pregnancies compared with controls.
Smoker 5/5 3/5 3/9 Caesarean section 5/5 5/5 8/9
In view of the probable role of NO in regulating blood flow Gestational age 30.9 Ϯ 1.7 35.5 Ϯ 1.3 a 31.9 Ϯ 3.5
within both the utero-placental and fetal-placental circulations (weeks) and the preliminary evidence for alterations in NO synthesis in pathological pregnancies (Lyall et al., 1995 (Lyall et al., , 1996 determined. Patient groups were compared using the Mann-Whitney
Materials and methods
U-test for non-parametric data. Tissues were collected from three groups of patients: (i) normotensive pregnant controls delivered in the third trimester of pregnancy for a logical placentas. Using non-parametric analysis, immuno- (Myatt et al., 1991 (Myatt et al., , 1992 . NO appears to contribute both to maintenance of basal vascular tone and to attenuate the action staining was significantly stronger in placentas of patients with of vasoconstrictors such as endothelin (ET-1) and thromboxane. IUGR compared with controls (P Ͻ0.05, Table III) . When this
We have demonstrated that the eNOS isoform is found in the was done for the effect of pre-eclampsia, it was not found to endothelium of the umbilical, chorionic plate and stem villous be statistically significant.
vessels, but not in the terminal villous capillary endothelium of the normotensive placenta (Myatt et al., 1993) . Pre-eclampsia is Discussion described as a state of endothelial dysfunction (Roberts et al. , Our previous studies have demonstrated the pharmacological 1991) in both maternal and fetal circulations. Evidence has been presented of altered prostaglandin I 2 (PGI 2 ) (Remuzzi action of NO in the human fetal-placental vasculature in vitro IUGR ϭ intrauterine growth restriction. IUGR ϭ intrauterine growth restriction; NS ϭ none seen. Intensity: 1 ϭ low; 2 ϭ moderate; 3 ϭ bright. Intensity: 1 ϭ low; 2 ϭ moderate; 3 ϭ bright. Localization: 1 ϭ basal; 2 ϭ continuous; 3 ϭ apical.
a Z ϭ -2.41, P Ͻ 0.05 (Mann-Whitney U-test) for IUGR group compared with control. a Z ϭ -2.014, P Ͻ 0.05 (Mann-Whitney U-test) for pre-eclampsia group compared with control.
waveforms, thought to be indicative of increased placental resistance . The previllous arterioles et al., 1980) and NO (Pinto et al., 1991) production by umbilical vessels from pre-eclamptic pregnancies, suggestive are probably the major determinant of resistance in the placental circulation. This increased resistance may be due to altered of endothelial dysfunction.
The fetal circulation in pre-eclampsia and/or IUGR is production of or response to vasoactive agents, but also perhaps to an altered vascular anatomy. Alterations in the vascular also characterized by abnormal umbilical blood flow velocity architecture with a reduced number of villous vessels, narrower eclamptic pregnancies (Ghabour et al., 1995) , but our current findings suggest it is not a unique feature of pre-eclampsia. lumens and thicker (muscular) vessel walls have been described in pre-eclampsia and/or IUGR . Interestingly, The common features linking the three groups of pathological pregnancies examined here are the abnormal umbilical flow infusion of the NO donor glyceryl trinitrate into the maternal circulation of pregnancies exhibiting such waveforms has been velocity waveforms and the alterations reported in the placental vasculature in such pregnancies (Giles reported to improve the umbilical flow velocity waveforms (Giles et al., 1992) , suggesting that NO may cross the placenta et al., 1985) . Those alterations include a smaller number of vessels in the terminal villi, a narrowing of the lumen of these and dilate the placental villous vasculature. However, maternal infusion of glyceryl trinitrate to either first trimester normal vessels and thickening of the smooth muscle in the vessel walls. The increased expression of eNOS detected in these pregnant women or to women in the second trimester who showed abnormal uterine artery blood flow at 24-26 weeks vessels by immunohistochemistry also agrees with our recent observation that concentrations of nitrate, a breakdown product has been shown to reduce uterine artery resistance as measured by ultrasound examination (Ramsay et al., 1994) . Therefore, of NO, are increased in umbilical venous blood from pregnancies complicated by pre-eclampsia and IUGR (Lyall et al. , NO donors will dilate the uterine circulation which may then trigger a response in the umbilical circulation independent 1995, 1996). These observations would also suggest that the altered eNOS expression observed in the villous vessels is not of NO transfer. In-vitro perfusion studies were unable to demonstrate that NO infused into the placental intervillous simply a reflection of endothelial dysfunction, for this has been described as a characteristic of pre-eclampsia (Roberts space could dilate the preconstricted fetal-placental circulation (Myatt et al., 1995) , supporting the concept that NO does not et al., 1991) but not of IUGR. In the pre-eclamptic human placenta, ultrastructural changes in the terminal villous vessels easily cross the placenta. We have previously shown that there was no overt difference in eNOS immunostaining in the have been described (Jones and Fox, 1980) . The stimulus to increased eNOS expression in villous vessel syncytiotrophoblast of the pre-eclamptic placenta when compared with controls (Ghabour et al., 1995) . Recently, Conrad endothelium is unclear. It may be indirect, resulting from vessel hypertrophy which arises from the increased transmural and Davis (1995) found no difference in eNOS activity measured in villous trophoblast dissected from normotensive pressure in the vessels. Alternatively, the stimulus may be direct. The promoter for the eNOS gene has a 'shear stress' or pre-eclamptic placentas. These current studies confirm and extend these observations. Syncytiotrophoblast eNOS response element (Marsden et al., 1992) . Decreasing the diameter of villous vessels will increase shear stress over the immunostaining was present in the normotensive group and in all groups of pathological placentas including pre-eclampsia endothelial cells which may then stimulate eNOS induction and also stimulate growth factor expression which could induce and/or IUGR. There was, however, an appreciable difference between the groups in the cellular localization of immunovascular smooth muscle cell growth/hypertrophy (Lyall and Deehan, 1994) . This eNOS would then produce NO as a staining in syncytiotrophoblast, although there was no difference in intensity or type (punctate or diffuse) of compensatory response to attempt to dilate the vessels and to lower resistance. The expression of eNOS might also be upimmunostaining. A significantly more basal distribution of eNOS immunostaining in syncytiotrophoblast was found in regulated by fetal-placental hypoxia, which complicates preeclampsia and IUGR. Locally-created focal ischaemia (Zhang placentas from patients with pre-eclampsia, with or without IUGR, compared with controls or with IUGR alone. has been shown by immunostaining to increase eNOS expression in rat cerebral vessel endothelium. feature therefore appears to be specific to pre-eclampsia. As syncytiotrophoblast functions as an endothelium lining the As pre-eclamptic and IUGR pregnancies share characteristic abnormal umbilical blood flow velocities indicative of intervillous space, this difference in cellular syncytiotrophoblast eNOS location may be analogous to other descriptions increased placental resistance and abnormal vascular anatomy, we feel that the increased eNOS expression in their vessels is of endothelial dysfunction in pre-eclampsia. Ultrastructural differences in the trophoblast of pre-eclamptic placentas includnot a disease-specific feature, but perhaps an adaptive response to increased resistance and poor perfusion. ing decreased pinocytotic activity and a decrease in secretory droplets have been reported (Jones and Fox, 1980) . The effect, however, on NO production by syncytiotrophoblast iseNOS staining in terminal villous vessels and stem villous alone. We have previously described this observation in pre-
